We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,649.50
Bid: 1,649.00
Ask: 1,649.50
Change: 13.50 (0.83%)
Spread: 0.50 (0.03%)
Open: 1,642.00
High: 1,656.00
Low: 1,635.00
Prev. Close: 1,636.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

13 Oct 2015 08:43

BROKER RATINGS SUMMARY: Citi Cuts AB Foods As UBS Raises Smiths Group

Read more
13 Oct 2015 07:39

LONDON MARKET OPEN: SABMiller Rises But FTSE 100 Hit By China Data

Read more
13 Oct 2015 07:17

LONDON BRIEFING: SABMiller Succumbs To AB InBev To Create Beer Giant

Read more
12 Oct 2015 19:27

BUZZ-GlaxoSmithKline PLC: JP Morgan says bear thesis played out, upgrades to "neutral"

(Updates RIC in 1st bullet) ** JP Morgan changes prior call on GlaxoSmithKline and lifts British drugmaker's stock to "neutral" ** Earnings expectations now look achievable, pipeline review suggests upcoming R&D day has positive risk/reward and stock's 6-pct dividend yield provides

Read more
12 Oct 2015 08:47

BROKER RATINGS SUMMARY: Investec Cuts Standard Chartered To Hold

Read more
12 Oct 2015 08:16

Glaxo makes European application for antiseptic gel

(ShareCast News) - GlaxoSmithKline has submitted a regulatory application to the European Medicines Agency for its antiseptic chlorhexidine gel for the prevention of umbilical cord infections in newborn babies. Glaxo said the EMA has granted the application accelerated assessment, a process open to

Read more
12 Oct 2015 07:55

Glaxo Submits European Regulatory Application For Chlorhexidine Gel

Read more
9 Oct 2015 10:50

UPDATE 2-J&J starts vaccine trial in Sierra Leone, even as Ebola fades

* Trial to test safety and immunogenicity of Ebola vaccine * J&J working with Bavarian Nordic on prime-boost vaccine (Adds executive comment, link to story on Ebola nurse) By Ben Hirschler Oct 9 (Reuters) - Johnson & Johnson has begun a clinical trial of a two-shot Ebola vacci

Read more
7 Oct 2015 23:00

Scientists call for urgent trials to judge flu drugs for pandemics

By Kate Kelland, Health and Science Correspondent LONDON, Oct 8 (Reuters) - Scientists still don't know if two commonly-used flu drugs -- Roche's Tamiflu and GlaxoSmithKline's Relenza -- really work in seasonal or pandemic flu outbreaks and say robust clinical trials are urgently needed to

Read more
1 Oct 2015 16:31

Glencore director backs company to the tune of nearly half a million pounds

(ShareCast News) - Glencore nearly bounced to pre-slump levels on Thursday, and director John Mack showed investors he's still backing the mining company. Shares in the FTSE 100-listed company dropped dramatically on Monday after Investec warned the stock holds little value for shareholders. But Jo

Read more
30 Sep 2015 08:46

UPDATE 2-WHO ramps up HIV drug push with call for early treatment for all

* WHO recommendation means 37 million should be on treatment * Early use of drugs extends lives, protects partners * MSF welcomes move but warns costs will soar (Adds details on costs) By Stephanie Nebehay GENEVA, Sept 30 (Reuters) - Everyone with HIV should be given ant

Read more
30 Sep 2015 04:01

U.S. biotech to apply artificial intelligence to UK genome study

By Julie Steenhuysen CHICAGO, Sept 30 (Reuters) - Berg, a private company that uses artificial intelligence to discover new drugs and diagnostics, will help England's national genomics project mine DNA and health data from thousands of British citizens for potential drug targets. Berg

Read more
24 Sep 2015 15:15

Dividends Calendar - Week Ahead

Read more
24 Sep 2015 14:17

GlaxoSmithKline Granted Approval To Market Mepolizumab Asthma Drug

Read more
24 Sep 2015 13:08

UPDATE 2-Novartis launches chronic disease programme for poor countries

* Scheme initially targets Kenya, Ethiopia, Vietnam * Treatments for hypertension, diabetes, breast cancer * Company plans eventually to roll out to 30 countries (Adds details on cost of medicines, spike in diabetes cases in Vietnam) By John Miller ZURICH, Sept 24 (Reute

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.